Trial · NCT02621060
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 22
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Fasting Plasma Glucose (FPG) | Week 12. | Reflect the fasting glucose level after a 10- to 12-h overnight fast. |
| Primary | 2 Hours Plasma Glucose (2-h PG) | Week 12. | Subjects underwent a 2-h oral glucose tolerance test (2-h OGTT) by consuming 75-g of a dextrose load, and one sample was obtained 120 min after glucose administration. |
| Primary | Glycated Hemoglobin A1c (A1C) | Week 12. | Shows what a person's average blood glucose level was for the 2 to 3 months before the test high-performance. |
| Primary | Total Insulin Secretion | Week 12. | After intervention. Total insulin secretion was calculated with the Insulinogenic index (Δ ABC insulin / Δ ABC glucose). |
| Primary | First Phase of Insulin Secretion | Week 12. | After intervention with Stumvoll index |
| Primary | Insulin Sensitivity | Week 12. | After intervention Matsuda Index |
| Secondary | Area Under the Curve of Glucose | Week 12. | Area under the curve of glucose was obtained using the trapezoidal integration. |
| Secondary | Area Under the Curve of Insulin | Week 12. | Before and after intervention area under the curve of insulin |
| Secondary | Body Weight | Week 12. | The weight was measured at baseline, week 4, week 8 and week 12 with a bioimpedance balance and the entered values reflect the weight at week 12 |
| Secondary | Body Mass Index | Week 12. | The Body Mass index was calculated at baseline and at week 12 with the Quetelet index and the entered values reflect the body mass index at week 12 |
| Secondary | Waist Circumference (WC) | Week 12. | Waist circumference was evaluated at baseline and at week 12 with a flexible tape and the entered values reflects the waist circumference measure at week 12 |
| Secondary | Systolic Blood Pressure (SBP) | Week 12. | The Systolic Blood Pressure was evaluated at baseline and week 12 with a digital sphygmomanometer and the entered values reflect the blood pressure at week 12 |
| Secondary | Diastolic Blood Plessure (DBP) | Week 12. | The Diastolic blood plessure was evaluated at baseline and week 12 with a digital sphygmomanometer and the entered values reflect the blood pressure at week 12 |
| Secondary | Triglycerides (TG) | Week 12. | The triglycerides were evaluated at baseline and week 12 with enzymatic-colorimetric techniques and the entered values reflect the triglycerides level at week 12 |
| Secondary | Total Cholesterol (TC) | Week 12. | The total cholesterol was estimated by standardized techniques at baseline and week 12 and the entered values reflect the total cholesterol level at week 12 |
| Secondary | High-density Lipoprotein Cholesterol (HDL-C) | Week 12. | The HDL-C levels were evaluated at baseline and week 12 with enzymatic/colorimetric techniques and the entered values reflect the HDL-C level at week 12 |
| Secondary | Low-density Lipoprotein Cholesterol (LDL-C) | Week 12. | The LDL-C levels were measured at baseline and at week 12 with standardized techniques and the entered values reflect the LDL-C levels at week 12 |
| Secondary | Very-low Density Lipoprotein (VLDL) | Week 12. | The VLDL levels were measured at baseline and at week 12 with standardized techniques and the entered values reflect the c-LDL levels at week 12 |
| Secondary | Glutamic Pyruvic Transaminase (GPT) | Week 12. | Before and after intervention by spectrophotometry |
| Secondary | Glutamic Oxaloacetic Transaminase (GOT) | Week 12. | Before and after intervention by spectrophotometry |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02621060/registered